Business Context and Reporting Period
This Form 8-K is a current report filed by Graybug Vision, Inc. (not Calcimedica, Inc.) on November 12, 2020. The registrant is a Delaware corporation with its principal executive offices in Redwood City, California, and its common stock trades on the Nasdaq Global Market under the symbol "GRAY". The filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a cover sheet referencing a press release rather than containing the financial data itself.
Material Changes
The filing references Item 2.02 Results of Operations and Financial Condition, indicating that the company made a public announcement disclosing material non-public information regarding its results of operations or financial condition for a completed fiscal period. The specific details of these results are contained in the attached press release (Exhibit 99.1) and are not summarized within the body of this 8-K text.
Guidance, Outlook, and Risks
The filing text does not contain specific management commentary, guidance, outlook, or risk factors. It notes that the registrant is an emerging growth company as defined by the Securities Act of 1933 and the Exchange Act of 1934. No specific risks or contingencies are detailed in the provided text.
Investor Verification Checklist
- Verify the actual financial results and operational metrics in Exhibit 99.1 (Press Release dated November 12, 2020), as the 8-K text only references this document.
- Confirm the specific fiscal period covered by the results of operations mentioned in Item 2.02.
- Review the press release for any forward-looking statements or guidance that may have been issued alongside the results.
- Note the discrepancy between the requested company name (Calcimedica, Inc.) and the actual registrant (Graybug Vision, Inc.).